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Impact of chronic kidney disease on outcomes
after abdominal aortic aneurysm repair
Virendra I. Patel, MD, Robert T. Lancaster, MD, Shankha Mukhopadhyay, MS,
Nathan J. Aranson, MD, Mark F. Conrad, MD, Glenn M. LaMuraglia, MD,
Christopher J. Kwolek, MD, and Richard P. Cambria, MD, Boston, Mass
Objective: Chronic kidney disease (CKD) is associated with increased morbidity and death after open abdominal aortic
aneurysm (AAA) repair (OAR). This study highlights the effect of CKD on outcomes after endovascular AAA (EVAR)
and OAR in contemporary practice.
Methods: The National Surgical Quality Improvement Program (NSQIP) Participant Use File (2005-2008) was queried
by Current Procedural Terminology (American Medical Association, Chicago, Ill) code to identify EVAR or OAR
patients, who were grouped by CKD class as having mild (CKD class 1 or 2), moderate (CKD class 3), or severe (CKD
class 4 or 5) renal disease. Propensity score analysis was performed to match OAR and EVAR patients with mild CKD
with those with moderate or severe CKD. Comparative analysis of mortality and clinical outcomes was performed based
on CKD strata.
Results:We identified 8701 patients who were treated with EVAR (n 5811) or OAR (n 2890) of intact AAAs. Mild,
moderate, and severe CKDwas present in 63%, 30%, and 7%, respectively. CKD increased (P< .01) overall mortality, with
rates of 1.7% (mild), 5.3% (moderate), and 7.7% (severe) in unmatched patients undergoing EVAR or OAR. Operative
mortality rates in patients with severe CKD were as high as 6.2% for EVAR and 10.3% for OAR. Severity of CKD was
associated with increasing frequency of risk factors; therefore, propensity matching to control for comorbidities was
performed, resulting in similar baseline clinical and demographic features of patients with mild compared with those with
moderate or severe disease. In propensity-matched cohorts, moderate CKD increased the risk of 30-day mortality for
EVAR (1.9% mild vs 3.2% moderate; P .013) and OAR (3.1% mild vs 8.4% moderate; P< .0001). Moderate CKD was
also associated with increased morbidity in patients treated with EVAR (8.3% mild vs 12.8% moderate; P < .0001) or
OAR (25.2% mild vs 32.4% moderate; P .001). Similarly, severe CKD increased the risk of 30-day mortality for EVAR
(2.6% mild vs 5.7% severe; P  .0081) and OAR (4.1% mild vs 9.9% severe; P  .0057). Severe CKD was also associated
with increased morbidity in patients treated with EVAR (10.6% mild vs 19.2% severe; P < .0001) or OAR (31.1% mild
vs 39.6% severe; P  .04).
Conclusions:The presence of moderate or severe CKD in patients considered for AAA repair is associated with significantly
increasedmortality and therefore should figure prominently in clinical decisionmaking. The highmortality of AAA repair
in patients with severe CKD is such that elective repair in such patients is not advised, except in extenuating clinical
circumstances. ( J Vasc Surg 2012;56:1206-13.)
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mPrevention of aneurysm-related death depends on
timely diagnosis and operative graft replacement of the
abdominal aorta or stent graft exclusion, with excellent
long-term durability.1-3 Surgical reconstruction is deferred
until the risk of aneurysm rupture outweighs operative
risks, with prospective trials defining a size threshold of 5.5
cm as appropriate for repair in most circumstances.4,5 En-
dovascular aneurysm repair (EVAR) is associated with sig-
nificant reduction in operative morbidity and mortality,6
and EVAR has gained widespread acceptance, with up to
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12060% of abdominal aortic aneurysms (AAAs) in the United
tates being repaired using EVAR.7 Despite the reduced
perative morbidity and mortality of AAA repair in con-
emporary practice, there remain subsets of patients for
hom elective open AAA repair (OAR) or EVAR remains
roblematic because of excessive perioperative risk or re-
uced long-term survival, independent of the AAA.8
Patients with intrinsic kidney disease represent one such
opulation, and individuals with chronic kidney disease (CKD)
ave significant cardiovascular comorbidities and reduced long-
erm survival in proportion to the severity of renal disease.9
umerous single-center and cohort studies have established pre-
perative renal dysfunction, defined by creatinine value, as an
ndependent predictor of increased postoperativemortality.10-15
he effect of graded CKD severity on operative mortality of
atients undergoing AAA repair has not been evaluated on a
arge-scale in contemporary practice.
ETHODS
This study evaluated the effect of CKD on operative
ortality of patients undergoing AAA repair using the
ational Surgical Quality Improvement Program (NSQIP)
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Volume 56, Number 5 Patel et al 1207Participant Use File (PUF) data set from 2005 to 2008.
The NSQIP PUF includes data from200 hospitals, rang-
ing from small private hospitals to large academic centers.
At participating hospitals, independent auditors review re-
cords and prospectively enter patient data on demographics
(six variables), surgical profile (11 variables), preoperative
data (44 variables), intraoperative variables (16), and 30-
day postoperative outcomes (20) for major procedures.
Details regarding clinical variables, 30-day outcomes, and
study definitions are publically available.16 Data complete-
ness and accuracy have been validated.17-20
This is a retrospective cohort study of the effect of CKD
severity on the primary outcome of 30-day (postoperative)
mortality in patients undergoing AAA (OAR or EVAR)
repair. Anymajor postoperative complication was evaluated
as a secondary outcome. Under the null hypothesis, pa-
tients undergoing AAA repair have similar 30-day mortality
regardless of CKD severity. Current Procedural Terminol-
ogy (American Medical Association, Chicago, Ill) codes
were used to determine patients undergoingOAR (35,081,
35,102) or EVAR (34,800, 34,802, 34,803) of an intact
(nonruptured) AAA, for whom CKD severity could be
objectively defined, and they were included in the study.
The effect of CKD was evaluated for each repair type.
The estimated glomerular filtration rate (eGFR) was
calculated for each patient using the Modified Diet in
Renal Disease equation21 (eGFR  186.3  serum creati-
nine–1.154 age–0.203 1.212 [if patient is black] 0.742
[if female]); only a preoperative serum creatinine value was
used to define eGFR. Patients were assigned to a CKD class
based on eGFR values according to National Kidney Foun-
dation clinical guidelines22: CKD 1 (normal)—eGFR90
mL/min/1.73 m2; CKD 2 (mild)—eGFR  60 to 89
mL/min/1.7 3 m2; CKD 3 (moderate)—eGFR  30 to
59mL/min/1.73 m2; CKD 4 (severe)—eGFR 15 to 29
mL/min/1.73 m2; and CKD 5 (kidney failure)—eGFR
15 mL/min/1.73 m2. Using CKD class, eGFR CKD sever-
ity was categorized as normal to mild (CKD class 1 or 2),
moderate (CKD class 3), and severe (CKD class 4 or 5).
Propensity score (PS) analysis was used to develop
matched cohorts of patients with mild vs moderate CKD as
well as mild vs severe CKD. Using 1:1 matching by PS,
cohorts of patients undergoing EVAR or OARwith mild vs
moderate CKD were created. Major contributors to the PS
for moderate CKD included American Society of Anesthe-
siology (ASA) class, current smoking, hypertension, diabe-
tes, cerebrovascular disease, coronary artery disease (CAD),
and emergency surgery. Similarly, PS analysis was used to
develop matched cohorts (2:1 matching) of patients with
mild vs severe CKD stratified by type of repair. Major
contributors to the PS for severe CKD were ASA class,
current smoking, hypertension, cerebrovascular disease,
peripheral vascular disease, and emergency surgery. The
difference in the major contributors of moderate or severe
CKD likely resulted from the differences in sample size (n
2632 moderate, and n  575 severe).
Cerebrovascular disease was defined as a history of
transient ischemic attack or stroke. CAD was defined as a fistory of angina (in the past 30 days), myocardial infarc-
ion (in the past 6months), previous coronary intervention,
r previous coronary bypass grafting. NSQIP defines emer-
ency surgery as any surgery performed 12 hours of
onscheduled admission or by designation as such by the
ttending surgeons or anesthesiologist. Peripheral vascular
isease with previous revascularization or amputation is
efined as a history of amputation or arterial revasculariza-
ion. Differences in baseline demographics, clinical fea-
ures, primary outcome, and secondary outcomes of open
urgery or EVAR patients by CKD severity were evaluated
n unmatched and propensity-matched cohorts.
Data analysis. Categoric variables are presented as
bsolute number and percentage frequencies, with contin-
ous data presented as mean values  standard deviation.
nivariate analysis was performed by using 2 or the Fisher
xact test for discrete variables, the t-test with equal vari-
nces for normally distributed continuous variables, and
he Wilcoxon rank-sum test for non-normally distributed
ontinuous and ordinal variables. PSs were generated for
he likelihood of having moderate or severe CKD for each
atient using logistic regression. Propensity matching was
erformed using the caliper method, matching case and
ontrol patients within 0.2 standard deviations of the PS.
esults with a P  .05 were considered statistically signifi-
ant. All statistical analysis was performed using SAS 9.2
oftware (SAS Institute, Cary, NC).
ESULTS
Using the NSQIP PUF, we identified 8701 patients
ndergoing repair of an intact AAA; of these, 5811 (67%)
ere treated with EVAR and 2890 (33%) underwent OAR.
ormal or mild CKD was present in 5495 (63%), and
oderate and severe CKD were present in 2632 (30%) and
75 (7%), respectively. Baseline demographics and clinical
eatures of the study population are notable for significant
ifferences across CKD strata for all clinical risk factors,
ith the exception of chronic obstructive pulmonary dis-
ase (Table I). Accordingly, the primary outcome of 30-day
perative mortality for all EVAR and OAR patients signif-
cantly increased with increasing CKD severity, from 1.7%
or mild to 5.3% for moderate to 7.6% for severe CKD (P
001). The unadjusted operative mortality for OAR was
.6% for mild, 9.1% for moderate, and 10.3% for severe
KD (P  .001). The unadjusted operative mortality for
VAR was 1.3% for mild, 3.2% for moderate, and 6.2% for
evere CKD (P  .001).
Matching by PS (1:1; moderate vs mild CKD) resulted
n 3460 matched patients treated with EVAR and 1740
atched patients treated with OAR. After PS analysis and
atching, patients with mild vs moderate CKD treated
ith EVAR or OAR had similar baseline demographic
nd clinical features (Table II). Differences in age, sex, race,
nd creatinine value represent characteristics that contrib-
te to the eGFR calculation by the Modified Diet in Renal
isease equation. Because eGFR was used to categorize
atients into CKD strata, these variables were excluded
rom the regression models used to generate the PS. Pa-
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November 20121208 Patel et altients with severe CKD were matched (1:2) with patients
with mild CKD based on PS, resulting in 1116 matched
EVAR patients and 569 matched OAR patients. The PS
Table I. Demographics and clinical features by severity of
and endovascular (EVAR) aneurysm repair patients
Variablea
Mild
(n  5494)
Age, years 72  9.1
Male sex 83.6
White race 85.2
Emergency case 5.3
ASA class 3 92.4
Tobacco use 36.6
Comorbidities
Hypertensionc 76.1
Diabetes 13
COPD 18.5
Cerebrovascular disease 12.7
Coronary artery diseasec 36.8
Peripheral vascular diseased 5.1
Dependent functional status 5.1
Creatinine, mg/dL 0.9  0.2
eGFR, mL/min/1.73 m2 82.7  22
ASA, American Society of Anesthesiology; COPD, chronic obstructive pulm
aContinuous variables are presented as mean  standard deviation; categori
bValues of P  .05 are statistically significant.
cRequiring medical therapy.
dIncludes history of congestive heart failure, myocardial infarction, previous
eWith previous revascularization or amputation.
Table II. Baseline demographic and clinical features of pr
kidney disease (CKD) undergoing endovascular (EVAR) a
Variablea
EVAR (1:1 match, n
Mild Modera
(n  1733) (n  172
Age, years 74  8.5 76  8
Male sex 76.3 66.3
White race 87.2 80.2
Emergency case 21.8 19.3
ASA class 3 95.9 96.0
Tobacco use 41.1 37.6
Comorbidities
Hypertensionc 86.6 90.1
Diabetes 12.8 13.9
COPD 17.4 19.3
Cerebrovascular disease 19.3 20.3
Coronary artery diseased 35.7 37.6
Peripheral vascular diseasee 7.6 6.9
Dependent functional status 11.2 11.9
Creatinine, mg/dL 1.0  0.2 1.4  0
eGFR, mL/min/1.73 m2 81.6  27.1 48.4  7
ASA, American Society of Anesthesiology; COPD, chronic obstructive pulm
aContinuous variables are presented as mean  standard deviation; categori
bValues of P  .05 are statistically significant.
cRequiring medical therapy.
dIncludes history of congestive heart failure, myocardial infarction, previous
eWith previous revascularization or amputation.matched cohorts of mild vs severe CKD undergoing OAR pepair were similar with respect to demographics and clin-
cal features (Table III). Patients with severe CKD under-
oing EVAR were more likely to undergo an emergency
nic kidney disease (CKD) for unmatched open (OAR)
CKD group
Pb
Moderate Severe
(n  2632) (n  575)
76  7.9 74  9.3 .0001
73.6 73 .0001
87.4 79.1 .0001
7.7 17.4 .0001
94.8 95.5 .0001
27.2 30.6 .0001
86.7 84.2 .0001
15.6 15.5 .0029
19 17.7 .75
18.7 20.2 .0001
42.9 37.7 .0001
6.8 13.2 .0001
6.8 13.2 .0001
1.5  0.3 3.6  2.0 .0001
48.2  7.9 20  7.1 .0001
disease; eGFR, estimated glomerular filtration rate.
bles as percentage of the patients.
taneous coronary intervention, and previous coronary artery bypass graft.
sity-matched patients with mild vs moderate chronic
pen (OAR) abdominal aortic aneurysm (AAA) repair
60) OAR: (1:1 match, n  1740)
Pb
Mild Moderate
Pb(n  867) (n  873)
.0001 70.1  9.2 74.1  7.5 .0001
.011 79.9 67.6 .0001
.026 85.8 87.5 .30
.48 10.1 8.5 .23
.94 95.5 95.6 .8
.41 35.1 35.7 .77
.23 88.2 88.7 .78
.72 14.0 12.1 .26
.58 15.9 19.0 .029
.78 18.0 17.5 .80
.65 41.9 41.5 .86
.76 7.5 6.1 .24
.80 6.6 6.8 .88
.0001 0.9  0.2 1.5  0.3 .0001
.0001 82.1  18.0 47.7  8.1 .0001
disease; eGFR estimated glomerular filtration rate.
bles as percentage of the patients.
taneous coronary intervention, and previous coronary artery bypass graft.chro
onary
c variaopen
nd o
 34
te
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.1
.3
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.007; Table III).
Perioperative outcomes for matched mild vs moderate
CKD patients are notable for increased mortality and in-
creased occurrence of any complication in patients with
moderate CKD compared with mild CKD for EVAR and
OAR (Table IV). Moderate CKD increased the risk of
prolonged ventilation (48 hours), postoperative dialysis-
dependent renal failure, and postoperative septic shock for
Table III. Baseline demographic and clinical features of p
disease (CKD) undergoing endovascular (EVAR) or open
Variablea
EVAR (1:2 match, n
Mild Severe
(n  746) (n  37
Age, years 73  8.9 75  9
Male sex 86.5 77.0
White race 84.0 78.7
Emergency case 11.3 15.7
ASA class 3 95.0 95.1
Tobacco use 25.9 26.8
Comorbidities
Hypertensionc 83.5 80.8
Diabetes 14.8 16.5
COPD 19.6 16.8
Cerebrovascular disease 19.8 20.0
Coronary artery diseased 39.7 37.8
Peripheral vascular diseasee 5.6 7.0
Dependent functional status 7.6 14.0
Creatinine, mg/dL 1.0  0.2 3.8  2
eGFR, mL/min/1.73 m2 81.5  17.0 19.3  7
ASA, American Society of Anesthesiology; COPD, chronic obstructive pulm
aContinuous variables are presented as mean  standard deviation; categori
bValues of P  .05 are statistically significant.
cRequiring medical therapy.
dIncludes history of congestive heart failure, myocardial infarction, previous
eWith previous revascularization or amputation.
Table IV. Postoperative outcomes of propensity-matched
undergoing endovascular (EVAR) or open (OAR) abdom
Variablea
EVAR (1:1 match
Mild Modera
(n  1733) (n  17
30-day mortality 1.9 3.2
Any complication 8.3 12.8
Wound complications 2.3 2.7
Pneumonia 1.9 2.4
Ventilation 48 hours 0.5 0.1
Acute renal failure 0.7 1.7
Stroke 0.5 0.8
Myocardial infarction 0.4 0.5
Cardiac arrest 0.5 0.6
Bleeding (4 units transfused) 0.6 1.0
Sepsis 1.1 1.5
Shock 0.9 1.9
aData are presented as percentage of the patients.
bValues of P  .05 are statistically significant.both repair types. For OAR, moderate CKD was associated fith increased postoperative bleeding (4.5% moderate vs
.3% mild; P  .013). Outcomes for matched mild vs
evere CKD patients showed increased postoperative mor-
ality and complications in patients with severe CKD (Table
). Severe CKD was associated with prolonged ventilation
nd postoperative dialysis-dependent renal failure in both
ypes of repair (Table V). For patients treated with EVAR,
evere CKD also increased the risk of postoperative pneu-
onia, cardiac arrest, bleeding requiring4 units of trans-
nsity-matched patients with mild vs severe chronic kidney
R) repair of abdominal aortic aneurysms (AAAs)
16) OAR (1:2 match, n  569)
Pb
Mild Severe
Pb(n  367) (n  202)
.0032 70.0  8.8 72.4  9.7 .0022
.0001 76.3 66.3 .011
.026 87.2 80.2 .027
.037 21.8 19.3 .48
.94 95.9 96.0 .94
.75 41.1 37.6 .41
.26 86.7 90.1 .23
.45 12.8 13.9 .72
.25 17.4 19.3 .58
.95 19.3 20.3 .78
.55 35.7 37.6 .65
.36 7.6 6.9 .76
.0007 11.2 11.9 .80
.0001 0.9  0.2 3.3  2.0 .0001
.0001 81.8  19.7 21.3  6.7 .0001
disease; eGFR, estimated glomerular filtration rate.
bles as percentage of the patients.
taneous coronary intervention, and previous coronary artery bypass graft.
nts with mild vs moderate chronic kidney disease (CKD)
ortic aneurysm (AAA) repair
460) OAR (1:1 match n  1740)
Pb
Mild Moderate
Pb(n  867) (n  873)
.013 3.1 8.4 .0001
.0001 25.2 32.4 .001
.5 5.0 4.9 .97
.29 9.7 11.2 .29
.018 10.6 14.3 .019
.005 2.5 6.0 .0004
.2 1.0 1.4 .52
.79 0.6 1.4 .091
.65 1.9 2.1 .74
.19 2.3 4.5 .013
.36 5.9 4.9 .38
.014 5.2 10.1 .0001rope
(OA
 11
0)
.0
.0
.3
onary
c variapatie
inal a
n  3
te
27)usion, sepsis, and septic shock (Table V). There were no
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November 20121210 Patel et aldifferences in postoperative wound complications, stroke,
or myocardial infarction inmatchedmild vs moderate CKD
and mild vs severe CKD severity for EVAR or OAR.
DISCUSSION
The extant literature has several limitations regarding
the effect of chronic renal insufficiency (CRI) on outcomes
of AAA repair. A number of studies are limited by very small
size10,11 or are not generalizable because they reflect out-
comes from referral center practices.13,23,24 Many studies
have inconsistently defined renal dysfunction, by way of a
threshold value in serum creatinine10-14,23,24 or by the
presence or absence of dialysis-dependent renal failure.15 In
administrative cohort studies using claims data, the exact
physiologic definition of CRI based on International Clas-
sification of Diseases, 9th Clinical Modification, coding is
undefined.15,25,26 Use of a serum creatinine value as a
surrogate for renal function is a major limitation for several
reasons. Serum creatinine, a point of care value, may be
affected by extraneous factors such as nutritional intake,
contrast-enhanced computed tomography imaging, pa-
tient medications, and patient factors reflecting creatinine
production, such as age, body mass index, weight, sex, and
race.
Compared with previous studies that defined CRI by a
threshold creatinine value, our study has the advantage of
using National Kidney Foundation guidelines to evaluate
the effect of CKD severity on operative death after AAA
repair.22 The robust clinical detail available in the NSQIP
data set allowed us to accurately determine eGFR and CKD
severity using validated clinical data for all patients included
in our study. Our study findings suggest a dose response,
with increasing rates of operative mortality and complica-
tions associated with increasing severity of CKD. Similar to
previous publications,10-15,23-26 our results show that there
is an increase in operative complications and death in
Table V. Postoperative outcomes of propensity-matched p
undergoing endovascular (EVAR) and open (OAR) abdom
Variablea
EVAR (1:2 match,
Mild Severe
(n  746) (n  37
30-day mortality 2.6 5.7
Any complication 10.6 19.2
Wound complications 2.9 3.8
Pneumonia 2.3 3.8
Ventilation 48 hours 2.6 4.9
Acute renal failure 0.9 6.2
Stroke 0.5 1.6
Myocardial infarction 0.7 1.1
Cardiac arrest 0.7 1.9
Bleeding (4 units transfused) 0.7 1.9
Sepsis 1.5 3.2
Shock 1.2 3.2
aData are presented as percentage of the patients.
bValues of P  .05 are statistically significant.patients with CKD. Yet our data also indicate that CKD is Imarker for increased incidence of other comorbidities
eg, CAD); accordingly, the power of large databases to
orrect for potentially confounding variables is evident.
ropensity-matched analysis resulted in matched cohorts
voiding confounding by such factors, and the operative
ortality and morbidity we have reported reflect the effect
f moderate and severe CKD independent of other opera-
ive risk factors.
Numerous large cohort studies14,15,25 have previously
ighlighted the negative effect of renal dysfunction on
urvival after OAR, similar to our findings. The prospective
anadian Aneurysm Study,14 a multicenter (77 surgeons)
rospective study of elective OAR, reported an operative
ortality of 4.8% in 666 patients. In this early study, CRI,
efined as serum creatine 1.25 mg/dL, significantly in-
reased operative mortality (9.9% CRI vs 2.8% no CRI;
 .001) and morbidity (11.8% CRI vs 4.2% no CRI; P
001). Katz et al,15 reporting operative mortality rates for
ntact and ruptured OAR across the state of Michigan,
imilarly noted increased mortality associated with pre-
xisting renal failure. In this study of 8185 intact and 1829
uptured AAAs, operative mortality for intact AAA repair
as increased (41.2% vs 6.2%; P  .001) in patients with
enal failure. In addition, renal failure was the strongest
ndependent predictor of death for intact AAA repair
odds ratio [OR], 9.0; 95% confidence interval [CI],
.7-11.4; P  .001).15
Using the National Inpatient Sample from 1994 to
996, Huber et al25 reported a mortality rate of 4.2% in
6,450 patients undergoing OAR. Their study similarly
oted that renal insufficiency was one of the strongest
ndependent predictors of operative mortality (OR, 9.5;
5% CI, 7.7-11.7; P  .001). The clinical definition of
enal insufficiency used is unclear and likely varied signifi-
antly, dependent on interpretation by a multitude of indi-
iduals completing discharge abstracts for the (National
nts with mild vs severe chronic kidney disease (CKD)
aortic aneurysm (AAA) repair
1116) OAR (1:2 match, n  569)
Pb
Mild Severe
Pb(n  367) (n  202)
.0081 4.1 9.9 .0057
.0001 31.1 39.6 .04
.46 4.1 5.9 .32
.042 13.4 12.9 .87
.0001 13.6 22.8 .0053
.0001 3.0 9.4 .001
.055 1.9 1.0 .21
.20 0.3 1.0 .24
.046 3.0 3.0 .99
.046 3.0 5.0 .24
.05 6.5 10.4 .1
.018 7.4 6.9 .85atie
inal
n 
0)npatient Sample) claims data set. Our study based the
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ria using validated patient data and is therefore easily and
reliably applicable in clinical practice. Our contemporary
mortality rates in all patients treated with OAR are in
keeping with other published results.14,15,25
Similar to the reports cited above, we also note that
patients undergoing OAR have increased mortality and
morbidity associated with worsening renal function. Com-
pared with patients with mild CKD, propensity-matched
patients with moderate and severe CKD had significantly
increased operative mortality rates of 8.4% and 9.9%, re-
spectively. These rates are low compared with the very high
42% mortality rate reported by Katz et al,15 likely related to
selection of the highest-risk (end-stage renal disease) pa-
tients into the renal dysfunction group in their study.
Similarly, the higher rates of mortality reported byHuber et
al25 (OR, 9.5) represent selection bias associated with the
unclear definition of renal insufficiency inherent to claims
data. In our study, the mortality rates of CKD patients
undergoing OAR were similar to published results (2 de-
cades old) for CRI patients from the Canadian Aneurysm
Study,14 which included lower-risk patients (serum creati-
nine closer to 1.25 mg/dL). These findings suggest that
the negative effect of renal dysfunction on operative mor-
bidity and mortality after open AAA repair has remained
relatively unchanged despite significant advances inmedical
care over time.
There have been conflicting reports on the effect of
CKD on death after EVAR. Mehta et al27 evaluated the
effect of elevated creatinine on outcomes after EVAR.
These investigators used serum creatinine values to assign
EVAR patients into differing categories of risk and found
no effect of elevated creatinine on postoperative death or
renal dysfunction. Using Medicare data, Egorova et al26
identified renal failure with dialysis (OR, 7.1; 95% CI,
5.2-9.5; P  .001) and without dialysis (OR, 1.9; 95% CI,
1.5-2.5; P  .001) as independent risk factors for death
after EVAR. In a study similar to ours that used eGFR as a
predictor of operative death after EVAR, Azizzadeh et al28
noted an eGFR of 60 mL/min was a more sensitive
predictor of operative mortality after EVAR than a serum
creatinine threshold of 1.7 mg/dL. Our study similarly
shows significantly increased mortality associated with
moderate and severe CKD compared with patients with
normal renal function or mild CKD. Operative mortality
was 3.2% in EVAR patients with moderate CDK (eGFR 
48.4  7.8 mL/min) and 5.7% in those with severe CKD
(eGFR 19.3 7.3 mL/min), which varied slightly from
previously reported rates28 owing to the propensity match-
ing and the different eGFR categories used. In our study, a
higher proportion of EVAR patients were more likely to
undergo emergency surgery in the presence of severe CKD
despite propensity-matching algorithms, which may ex-
plain the increased mortality after EVAR in patients with
severe CKD. Analysis with exclusion of such patients did
not alter our findings or conclusions.
In the present study, we evaluated the effect of CKD on
outcomes in 8701 AAA patients undergoing EVAR or fAR with sufficient clinical detail to define CKD severity.
everal aspects of our study methodology bear consider-
tion, including statistical methods for propensity match-
ng, statistical analysis, and resulting sample size reduction.
ll patients in our study were assigned a PS for moderate or
evere CKD. Patients with moderate and severe CKD were
atched with patients having mild CKD, resulting in well-
atched cohorts, as evidenced by the data (Table II and
II). We did not include age, race, and sex in the logistic
egression models used to generate the PS because these
actors contribute to the calculation of eGFR upon which
KD severity stratification is based. Inclusion of such fac-
ors would have reduced our comparison groups to differ-
nces in baseline creatinine value alone, which has been a
imitation of previous publications on this topic, as noted
bove.
The alternative strategy of using a logistic regression
odel to evaluate the effect of CKD severity on outcomes
ndependent of clinical risk factors, including age, sex, race,
nd other risk factors, such as emergency surgery, was used
o validate our results, with no effect on study conclusions.
recent meta-analysis reported the concordance of find-
ngs when comparing propensity score methods with tradi-
ional regression models.29 After propensity matching,
nalysis was performed using standard statistical tests. Al-
hough patients with mild CKD were matched to those
ith moderate and severe CKD for comparison, the match-
ng algorithm was based on the PS and not individual
atient attributes for which a paired t-test or the McNemar
est would have been more appropriate. Using the PS to
atch, patients were not matched by specific features but
y a numeric value (PS  0.2 standard deviations) derived
rom a variety of risk factors. As such, two patients with
imilar PS scores might not bematched for the same clinical
isk factors because eight factors were used to derive the PS
or moderate CKD and six for severe CKD. We therefore
etermined it was inappropriate to use paired statistical
ests.
Lastly, our methodology resulted in smaller matched
ohorts for analysis. Appropriate numbers of patients with
ild or moderate CKD were available to ensure adequate
tatistical power for comparison. Direct comparison of
atients with moderate CKD to patients with severe CKD
as not feasible because of the limited number of patients
ith severe CKD. The small number of patients with severe
KD (7%) may be reflective of the conservative posture
oward AAA repair in such patients. Despite this limitation,
urs is the largest study to date evaluating the role of CKD
n outcomes of AAA repair.
Another limitation of this study is related to the defi-
iencies of the NSQIP data set. The data set does not
nclude risk factor severity or information specific to spe-
ialty, hospital, or surgeon. In the case of CAD, informa-
ion on CAD severity, exercise capacity, and cardiac func-
ion would have been more valuable because patients with
ncreasing CKD severity are likely to have increasingly
evere CAD. In addition, we used a composite definition
or CAD to designate presence or absence of CAD; thus,
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Despite lack of specificity in CAD severity, cardiovascular
events were similar in the mild vs moderate and mild vs
severe cohorts. Additional data on aneurysm anatomy
(neck, access vessels, need for conduit placement, neck size
and length, neck angulation), indications for repair (size,
growth rate, symptoms), location of the aortic clamp in
OAR, and the type of EVAR repair performed were not
available to include in the propensity-matching algorithm.
Availability of clinically relevant technical differences
across CKD strata would have further strengthened our
analysis. Information on hospital type, hospital volume,
and surgeon volume, which have been reported to affect
outcomes of AAA repair, are not available in this data set.
NSQIP outcomes are limited to 30 days from the index
procedure therefore are only applicable to perioperative
surgical decision making. Long-term outcomes important
for decision making are unavailable in our data set.
Despite these limitations, the data set has numerous
strengths, which include a large number of patients, inde-
pendent acquisition of data, validated data integrity, the
time period (2005-2008) represented, and the PS match-
ing to correct for differences across CKD strata. As such,
our study findings are widely applicable because our data
reflect contemporary real-world practice without the power
limitations of small studies or the generalizability limita-
tions of large single-center studies and include sufficient
clinical detail to effectively assess the effect of CKD on
outcomes of AAA repair.
In the Endovascular Aneurysm Repair 2 (EVAR 2)
trial,8 patients deemed high risk for open repair (predomi-
nantly for cardiac or pulmonary reasons) were randomized
to EVAR or best medical therapy. The 30-day mortality for
high-risk patients randomized to EVAR was 9%, and long-
term survival of these patients was40% at 4 years, with no
mortality benefit afforded by EVAR. The operative mortal-
ity rates reported in our study for EVAR (5.7%matched and
6.3% unmatched) and OAR (9.9% matched and 10.3%
unmatched) patients with severe CKD are similar to oper-
ative mortality from EVAR 2. In addition, given the pro-
portionally increased all-cause mortality in patients with
worsening CKD (ie, decreasing eGFR),9 the presence of
moderate and especially severe CKD should figure promi-
nently in the decision to electively repair an AAA. Given the
low rupture risk4,5 of patients with aneurysms sized 4 to 5.5
cm, the anatomic size threshold for elective repair in such
high-risk patients should perhaps be studied further or
increased to 6 to 6.9 cm, where probable annual rupture
rates30,31 approach operative mortality risk. High-risk pa-
tients (moderate or severe CKD) with symptomatic or
rapidly growing aneurysms may be considered for repair
after risk-benefit analysis.
CONCLUSIONS
Our study collating contemporary data from a spec-
trum of hospitals and surgeons with a range of experience
and volume shows that moderate and severe CKD predict
increased operative mortality and morbidity after EVAR orAR. In patients with severe CKD, operative risks are
rohibitive to elective repair; therefore, AAA repair in pa-
ients with severe CKD should be avoided except in exten-
ating clinical circumstances.
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